SelvitaWAR:SLV +3.27%80 Market Cap is zł579.9 Mil as of Jun. 28, 2026. GuruFocus rates WAR:SLV with a GF Score™ of 80/100 and a GF Value™ of zł58.46 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 218 Medical Diagnostics & Research companies, Selvita ranks better than 59.17% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Selvita's share price for the quarter that ended in Mar. 2026 was zł35.1. Selvita's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 18.4 Mil. Therefore, Selvita's market cap for the quarter that ended in Mar. 2026 was zł644.2 Mil.
Selvita's quarterly market cap
increased
from Sep. 2025 (zł701.2 Mil) to Dec. 2025 (zł792.8 Mil) but then
declined
from Dec. 2025 (zł792.8 Mil) to Mar. 2026 (zł644.2 Mil).
Selvita's annual market cap
declined
from Dec. 2023 (zł1,073.8 Mil) to Dec. 2024 (zł908.6 Mil) and
declined
from Dec. 2024 (zł908.6 Mil) to Dec. 2025 (zł792.8 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Selvita's Enterprise Value for Today is zł728.0 Mil.
Selvita (WAR:SLV) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Selvita Market Cap Related Terms
Selvita Market Cap Historical Data
* Premium members only.
The historical data trend for Selvita's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Selvita's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Selvita Market Cap vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Selvita's Market Cap distribution charts can be found below:
* The bar in red indicates where Selvita's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Selvita's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Selvita (WAR:SLV) has a Market Cap of zł579.9 Mil as of Jun. 28, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Selvita and its competitors. According to the industry distribution chart, Selvita ranks #89 out of 218 companies in the Medical Diagnostics & Research industry, placing it in the top 40.8%.
Is Selvita's Market Cap too high?
Selvita's current Market Cap is zł579.9 Mil. Based on the distribution chart, Selvita ranks #89 out of 218 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Selvita has a GF Score™ of 80/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Selvita's Market Cap compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Selvita ranks #89 out of 218 companies for Market Cap. This puts Selvita in the upper half of its industry. The industry median Market Cap is 55.55. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Diagnostics & Research company?
The median Market Cap among Medical Diagnostics & Research companies is 55.55, based on 218 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Selvita and its competitors. For the Medical Diagnostics & Research industry, the median Market Cap is 55.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Selvita's current Market Cap is zł579.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Selvita stock overvalued right now?
Based on GuruFocus' analysis, Selvita (WAR:SLV) is currently considered Significantly Undervalued. The stock's GF Value™ is zł58.46, compared to a current price of zł31.60 — trading 45.9% below its estimated fair value. The current Market Cap is zł579.9 Mil. Selvita's overall GF Score™ is 80/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Selvita (WAR:SLV), the current Market Cap is zł579.9 Mil as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Selvita (WAR:SLV) Overvalued in 2026?
Based on GuruFocus' analysis, Selvita stock appears to be undervalued.
The current stock price of zł31.60 is trading 45.9% below its estimated GF Value™ of zł58.46.
GuruFocus considers Selvita to be Significantly Undervalued.
Key valuation signals for WAR:SLV:
Market Cap: zł579.9 Mil
GF Value™: zł58.46 vs. price of zł31.60 (45.9% below fair value)
No single metric tells the full story. See the WAR:SLV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Selvita SA is a Poland based parent company of Selvita Group is one of the largest preclinical contract research organizations in Europe. It also develops bioinformatics solutions supporting innovative projects at preclinical stages. It also provides services provided to external contractors are in the field of chemistry, analytics, regulatory, biochemistry and cell biology and also the integrated research and development projects.
80GF Score
Get the complete analysis for WAR:SLV
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:SLV has been successfully added to your 
